Desirée Montoro-Cárdenas

Ms. Desirée Montoro-Cárdenas

University of Jaén, Jaén, Andalusia, Spain
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
DMDesirée Montoro-Cárdenas
Desirée Montoro-Cárdenas
Irene Cortés-PérezIrene Cortés-Pérez
Irene Cortés-Pérez
MLMaría del Rocío Ibancos Losada
María del Rocío Ibancos Losada
Noelia Zagalaz-AnulaNoelia Zagalaz-Anula
Noelia Zagalaz-Anula
Esteban Obrero-GaitánEsteban Obrero-Gaitán
Esteban Obrero-Gaitán
María Catalina Osuna-PérezMaría Catalina Osuna-Pérez
María Catalina Osuna-Pérez
Background: Nintendo® Wii-based therapy (NWT) is a non-immersive virtual reality therapy used to recover upper extremity (UE) motor function in children with cerebral palsy (CP). We aimed primarily to elucidate the effectiveness of NWT in improving UE motor and functional impaired abilities in children with CP, compared to conventional therapy or no intervention. The secondary aim was to assess if NWT is more effective when used alone or combined with conventional therapy. Methods: A systematic review with meta-analysis was conducted from a bibliographic search in PubMed, Scopus, PEDro, Web of Science, and CINHAL, ending in October 2021, in accordance with PRISMA guidelines. We included randomized controlled trials that compared NWT vs. conventional therapy or no intervention in terms of their impact on different UE impaired abilities (grip strength, tip grip strength, UE dissociated movements, functional capacity in daily living activities, gross and fine motor dexterity, and grasping ability) in children with CP. Effect size was calculated with standardized mean difference (SMD) and its 95% confidence interval (95% CI). Results: Nine studies (276 participants) were included. NWT is more effective than conventional therapy at improving grip strength (SMD = 0.5, 95% CI 0.08, 0.91), tip grip strength (SMD = 0.95, 95% CI 0.3, 1.61), and grasping ability (SMD = 0.72, 95%CI 0.14, 1.3). NWT is more effective than conventional therapy at improving functional capacity in daily living activities (SMD = 0.83, 95% CI 0.07, 1.56). For fine manual dexterity, NWT was better than no intervention (SMD = 3.12, 95% CI 1.5, 4.7). Conclusions: Our results indicate that NWT is effective at improving various UE impaired motor skills in children with CP.

15 March 2021 in Sensors
Verified
Journal Article
Open access
PDF file
Irene Cortés-PérezIrene Cortés-Pérez
Irene Cortés-Pérez
Noelia Zagalaz-AnulaNoelia Zagalaz-Anula
Noelia Zagalaz-Anula
DMDesirée Montoro-Cárdenas
Desirée Montoro-Cárdenas
Rafael Lomas-VegaRafael Lomas-Vega
Rafael Lomas-Vega
Esteban Obrero-GaitánEsteban Obrero-Gaitán
Esteban Obrero-Gaitán
María Catalina Osuna-PérezMaría Catalina Osuna-Pérez
María Catalina Osuna-Pérez
Leap Motion Controller (LMC) is a virtual reality device that can be used in the rehabilitation of central nervous system disease (CNSD) motor impairments. This review aimed to evaluate the effect of video game-based therapy with LMC on the recovery of upper extremity (UE) motor function in patients with CNSD. A systematic review with meta-analysis was performed in PubMed Medline, Web of Science, Scopus, CINAHL, and PEDro. We included five randomized controlled trials (RCTs) of patients with CNSD in which LMC was used as experimental therapy compared to conventional therapy (CT) to restore UE motor function. Pooled effects were estimated with Cohen’s standardized mean difference (SMD) and its 95% confidence interval (95% CI). At first, in patients with stroke, LMC showed low-quality evidence of a large effect on UE mobility (SMD = 0.96; 95% CI = 0.47, 1.45). In combination with CT, LMC showed very low-quality evidence of a large effect on UE mobility (SMD = 1.34; 95% CI = 0.49, 2.19) and the UE mobility-oriented task (SMD = 1.26; 95% CI = 0.42, 2.10). Second, in patients with non-acute CNSD (cerebral palsy, multiple sclerosis, and Parkinson’s disease), LMC showed low-quality evidence of a medium effect on grip strength (GS) (SMD = 0.47; 95% CI = 0.03, 0.90) and on gross motor dexterity (GMD) (SMD = 0.73; 95% CI = 0.28, 1.17) in the most affected UE. In combination with CT, LMC showed very low-quality evidence of a high effect in the most affected UE on GMD (SMD = 0.80; 95% CI = 0.06, 1.15) and fine motor dexterity (FMD) (SMD = 0.82; 95% CI = 0.07, 1.57). In stroke, LMC improved UE mobility and UE mobility-oriented tasks, and in non-acute CNSD, LMC improved the GS and GMD of the most affected UE and FMD when it was used with CT.

11 April 2023 in Journal of NeuroEngineering and Rehabilitation
Verified
Journal Article
Open access
PDF file
Irene Cortés-PérezIrene Cortés-Pérez
Irene Cortés-Pérez
María Catalina Osuna-PérezMaría Catalina Osuna-Pérez
María Catalina Osuna-Pérez
DMDesirée Montoro-Cárdenas
Desirée Montoro-Cárdenas
Rafael Lomas-VegaRafael Lomas-Vega
Rafael Lomas-Vega
Esteban Obrero-GaitánEsteban Obrero-Gaitán
Esteban Obrero-Gaitán
Francisco Nieto EscámezFrancisco Nieto Escámez
Francisco Nieto Escámez
Objective: This study aims to conduct a meta-analysis to assess the effect of virtual reality-based therapy (VRBT) on balance dimensions and fear of falling in patients with multiple sclerosis (PwMS). Secondarily, to determine the most recommendable dose of VRBT to improve balance. Methods: PubMed Medline, Web of Science, Scopus, CINAHL and PEDro were screened, without publication date restrictions, until September 30th, 2021. Randomized controlled trials (RCTs) comparing the effectiveness of VRBT against other interventions in PwMS were included. Functional and dynamic balance, confidence of balance, postural control in posturography, fear of falling and gait speed were the variables assessed. A meta-analysis was performed by pooling the Cohen's standardized mean difference (SMD) with 95% confidence interval (95% CI) using Comprehensive Meta-Analysis 3.0. Results: Nineteen RCTs, reporting 858 PwMS, were included. Our findings reported that VRBT is effective in improving functional balance (SMD = 0.8; 95%CI 0.47 to 1.14; p < 0.001); dynamic balance (SMD = − 0.3; 95%CI − 0.48 to − 0.11; p = 0.002); postural control with posturography (SMD = − 0.54; 95%CI − 0.99 to − 0.1; p = 0.017); confidence of balance (SMD = 0.43; 95%CI 0.15 to 0.71; p = 0.003); and in reducing fear of falling (SMD = − 1.04; 95%CI − 2 to − 0.07; p = 0.035); but not on gait speed (SMD = − 0.11; 95%CI: − 0.35 to 0.14; p = 0.4). Besides, the most adequate dose of VRBT to achieve the greatest improvement in functional balance was at least 40 sessions, five sessions per week and 40–45 min per sessions; and for dynamic balance, it would be between 8 and 19 weeks, twice a week and 20–30 min per session. Conclusion: VRBT may have a short-term beneficial role in improving balance and reducing fear of falling in PwMS.

11 December 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
Esteban Obrero-GaitánEsteban Obrero-Gaitán
Esteban Obrero-Gaitán
DMDesirée Montoro-Cárdenas
Desirée Montoro-Cárdenas
Irene Cortés-PérezIrene Cortés-Pérez
Irene Cortés-Pérez
María Catalina Osuna-PérezMaría Catalina Osuna-Pérez
María Catalina Osuna-Pérez
Background: Mechanical horse-riding simulator (HRS) exercises are a type of therapy based on the use of robotic or mechanical devices that produces movement similar to a real horse with the aim of simulating hippotherapy. This review analyses the effectiveness of HRS therapies in patients with cerebral palsy (CP). Methods: A systematic review and a meta-analysis were carried out by searching studies in PubMed Medline, SCOPUS, Web of Science, CINAHL, PEDro and SciELO up until October 2022. We selected clinical trials that assessed the effectiveness of HRS therapy, compared to other interventions, in patients with CP. The main variables were gross motor function (its global score and dimensions, such as sitting ability), functional balance, spasticity, hip range of motion (ROM), posturographic balance and satisfaction. The risk of bias was assessed using the Cochrane Risk of Bias Tool. The pooled effect was calculated using Cohen’s Standardized Mean Difference (SMD) for a 95% confidence interval (95% CI). Results: Twelve studies were included in the systematic review, and 10 were included in the meta-analysis, providing data from 343 patients with spastic diplegic CP. Our findings revealed that HRS plus physiotherapy is more effective than physiotherapy in improving the total gross motor function (SMD 0.98; 95% CI 0.35–1.62), sitting ability of the gross motor function (SMD 0.84; 95% CI 0.32–1.36) and functional balance (SMD 0.6; 95% CI 0.1–1.08), and HRS therapy is better than sham to improve pelvic abduction ROM (SMD 0.79; 95% CI 0.21–1.37). Conclusions: Horse-riding simulator-based therapy is an effective therapy to improve gross motor function, functional balance and abduction pelvic ROM in children with CP, in comparison to physiotherapy or sham.

28 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MLMaría del Rocío Ibancos Losada
María del Rocío Ibancos Losada
María Catalina Osuna-PérezMaría Catalina Osuna-Pérez
María Catalina Osuna-Pérez
Irene Cortés-PérezIrene Cortés-Pérez
Irene Cortés-Pérez
DMDesirée Montoro-Cárdenas
Desirée Montoro-Cárdenas
Ángeles Díaz-FernándezÁngeles Díaz-Fernández
Ángeles Díaz-Fernández
Experimental pain testing requires specific equipment and may be uncomfortable for patients. The Pain Sensitivity Questionnaire (PSQ) was developed to assess pain sensitivity, based on the pain intensity ratings (range: 0–10) of painful situations that occur in daily life. The main objective of this study was to carry out a cross-cultural adaptation and validation of the Spanish version of the PSQ (PSQ-S). A total of 354 subjects (296 healthy and 58 chronic pain patients) filled in the PSQ-S. A subgroup of 116 subjects performed experimental pain testing, including two modalities (cold and pressure), with different measures: pain intensity rating, pressure pain threshold, and tolerance. The validation results showed two factors: PSQ-S-moderate and PSQ-S-minor and, for the total scale and the two factors, an excellent internal consistency (Cronbach’s alpha coefficient > 0.9) and a substantial reliability (Intraclass Correlation Coefficient > 0.8). We obtained strong correlations with all the experimental pain rating parameters, catastrophizing, and depression variables, as well as moderate correlations with anxiety, central sensibilization, and impact on the quality of life. Chronic pain patients received elevated PSQ-S scores compared to healthy controls, and three cut-off values (PSQ-S-total = 7.00, PSQ-S-moderate = 7.57, and PSQ-S-minor = 6.29) based on ROC curve analyses were shown to be able to discriminate between healthy adults and adults with chronic pain. Therefore, PSQ-S may be a simple alternative to experimental pain procedures for clinical and experimental pain research.